BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24228252)

  • 1. Pulmonary hypertension in Portugal: first data from a nationwide registry.
    Baptista R; Meireles J; Agapito A; Castro G; da Silva AM; Shiang T; Gonçalves F; Robalo-Martins S; Nunes-Diogo A; Reis A
    Biomed Res Int; 2013; 2013():489574. PubMed ID: 24228252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
    Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
    Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of long-term prognosis among all subtypes of pulmonary hypertension in Japan.
    Kozu K; Sugimura K; Ito M; Hirata KI; Node K; Miyamoto T; Ueno S; Watanabe H; Shimokawa H;
    Int J Cardiol; 2020 Feb; 300():228-235. PubMed ID: 31813677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry].
    Valieva ZS; Martynyuk TV; Nakonechnikov SN; Chazova IE
    Ter Arkh; 2021 Sep; 93(9):1058-1065. PubMed ID: 36286865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry.
    Jansa P; Jarkovsky J; Al-Hiti H; Popelova J; Ambroz D; Zatocil T; Votavova R; Polacek P; Maresova J; Aschermann M; Brabec P; Dusek L; Linhart A
    BMC Pulm Med; 2014 Mar; 14():45. PubMed ID: 24629043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
    Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
    Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe.
    Skride A; Sablinskis K; Lejnieks A; Rudzitis A; Lang I
    Pulm Circ; 2018; 8(3):2045894018780521. PubMed ID: 29767576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study.
    Nagata J; Sekine A; Tanabe N; Taniguchi Y; Ishida K; Shiko Y; Sakao S; Tatsumi K; Suzuki T
    BMC Pulm Med; 2022 Jul; 22(1):282. PubMed ID: 35858889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in pulmonary hypertension in Spain: insights from the Spanish registry.
    Escribano-Subias P; Blanco I; López-Meseguer M; Lopez-Guarch CJ; Roman A; Morales P; Castillo-Palma MJ; Segovia J; Gómez-Sanchez MA; Barberà JA;
    Eur Respir J; 2012 Sep; 40(3):596-603. PubMed ID: 22362843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
    Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
    Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcomes in chronic thromboembolic pulmonary hypertension: From expert centers to a nationwide perspective.
    Escribano-Subías P; Del Pozo R; Román-Broto A; Domingo Morera JA; Lara-Padrón A; Elías Hernández T; Molina-Ferragut L; Blanco I; Cortina J; Barberà JA;
    Int J Cardiol; 2016 Jan; 203():938-44. PubMed ID: 26618257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.
    Chazova IE; Martynyuk TV; Valieva ZS; Nakonechnikov SN; Nedogoda SV; Salasyuk AS; Taran IN; Gratsianskaya SE
    Ter Arkh; 2018 Sep; 90(9):101-109. PubMed ID: 30701743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019-2020.
    Kauliņš R; Rudzītis A; Lejnieks A; Kigitoviča D; Skride A
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629717
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term data from the Swiss pulmonary hypertension registry.
    Mueller-Mottet S; Stricker H; Domenighetti G; Azzola A; Geiser T; Schwerzmann M; Weilenmann D; Schoch O; Fellrath JM; Rochat T; Lador F; Beghetti M; Nicod L; Aubert JD; Popov V; Speich R; Keusch S; Hasler E; Huber LC; Grendelmeier P; Tamm M; Ulrich S
    Respiration; 2015; 89(2):127-40. PubMed ID: 25661477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Chazova IE; Arkhipova OA; Martynyuk TV
    Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.
    Brown LM; Chen H; Halpern S; Taichman D; McGoon MD; Farber HW; Frost AE; Liou TG; Turner M; Feldkircher K; Miller DP; Elliott CG
    Chest; 2011 Jul; 140(1):19-26. PubMed ID: 21393391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.